Mindfulness course lifted sleep and mood in menopause

Menopause occupies nearly one-third of a woman's life, and it is commonly accompanied by sleep disturbances, mood fluctuations and a reduced quality of life — a burden the study's authors describe as a significant public health concern. Pharmacological treatments for menopausal symptoms carry well-documented risks, which pushes interest towards non-drug alternatives. Mindfulness-Based Stress Reduction (MBSR) is one of the best-known structured mindfulness programmes, yet it remains understudied in menopausal women, particularly across multiple psychosocial outcomes at once. This trial set out to test whether an MBSR programme could move quality of life, life satisfaction, sleep quality and mental well-being together in this population.

Researchers ran a randomised controlled trial with a pretest–posttest control-group design at a primary healthcare centre in Türkiye, with data collected between February and December 2025. A total of 84 menopausal women took part: 43 were assigned to the intervention and 41 to a control group that received no intervention. The intervention group completed an 8-week MBSR programme. Outcomes were measured with four validated instruments — the Utian Quality of Life Scale, the Riverside Life Satisfaction Scale, the Pittsburgh Sleep Quality Index and the Warwick-Edinburgh Mental Well-Being Scale — before and after the programme.

Compared with the control group, women who completed the MBSR programme showed statistically significant improvements in quality of life, life satisfaction and mental well-being, along with significant reductions in sleep disturbances (p < 0.001 for these comparisons). Within-group analyses told the same story: the intervention group improved significantly across all measured outcomes, whereas the control group showed no significant changes on any outcome (p > 0.05). The abstract reports statistical significance rather than the size of the improvements, so how large or clinically meaningful the changes were cannot be judged from it. No adverse effects were mentioned either way.

The authors note that non-pharmacological, evidence-based options such as MBSR have been understudied in menopausal women, so this trial adds randomised evidence to a relatively thin area, and it is unusual in tracking four psychosocial outcomes simultaneously. That said, the comparison was against no intervention at all, which means expectation and attention effects cannot be separated from the mindfulness training itself. Open questions include whether the benefits persist beyond the programme, how large the effects actually are, and whether results from a single Turkish primary healthcare centre generalise to other settings and populations.

For readers navigating menopause, this is a reason to think that structured mindfulness training belongs on the list of credible non-drug approaches for sleep and psychological well-being, alongside the caution that this is one modest trial rather than settled science. The finding that sleep disturbances eased alongside mood and life-satisfaction measures is consistent with the idea that stress-focused interventions can touch several aspects of well-being at once. It is not evidence that mindfulness replaces medical care for menopausal symptoms, and anyone weighing treatment options would still be looking at a field where more rigorous, larger trials are needed.